Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis
To date, relatively little is known about the economic and medical impact of Lyme borreliosis (LB) on European health care systems, especially for the inpatient sector. This retrospective analysis is based on data provided for the years 2007-2011 by a German statutory health insurance company (DAK-G...
Gespeichert in:
| Veröffentlicht in: | Ticks and tick-borne diseases 2015-02, Vol.6 (1), p.56-62 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 62 |
|---|---|
| container_issue | 1 |
| container_start_page | 56 |
| container_title | Ticks and tick-borne diseases |
| container_volume | 6 |
| creator | Lohr, B Müller, I Mai, M Norris, D E Schöffski, O Hunfeld, K-P |
| description | To date, relatively little is known about the economic and medical impact of Lyme borreliosis (LB) on European health care systems, especially for the inpatient sector. This retrospective analysis is based on data provided for the years 2007-2011 by a German statutory health insurance company (DAK-Gesundheit) covering approximately 6 million insured. Total cost was calculated for a 1-year period both from the third-party payers and from the societal perspective, respectively. In our cohort the incident diagnosis of LB was coded for 2163 inpatient cases during the years 2008-2011. The median inpatient time was 9 days resulting in a median direct medical cost per hospital stay of 3917€ for adolescents and 2843€ for adults. Based on extrapolation of our findings to the German population, we would expect an average hospital admission of 5200 adults and 2300 adolescents ( |
| doi_str_mv | 10.1016/j.ttbdis.2014.09.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629965462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1629965462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-2e5b2298da39f4ef162a6f8a57fcb6973c142f62aaa164556b290934ce2521a3</originalsourceid><addsrcrecordid>eNo9kE1r3DAQhkVJaUKafxCKjrmsK8mybPVWQpoWFnLJITcxtkdZLbK11WgPzik_vQ6bdC4zDO8HPIxdS1FJIc33fVVKPwaqlJC6ErYSQn9iF7Jr2401oj77uBv7dM6uiPZinVrqrlVf2LlqtO60Ehfs9e4QRpxCiul54TCPfEhUePJ8l-gQCkQ-QEbuU-bbZULep5wxhkSBeJj5PeYJ5uUHj0iUZuI-p4kD3yHEsjt5jyXE8AIlpJmPUKAHwrUK4rKGfGWfPUTCq_d9yR5_3T3e_t5sH-7_3P7cboZatGWjsOmVst0ItfUavTQKjO-gaf3QG9vWg9TKr08AaXTTmF5ZYWs9oGqUhPqS3ZxiDzn9PSIVNwUaMEaYMR3JrXnWmkYbtUr1STrkRJTRu0MOE-TFSeHe6Lu9O9F3b_SdsG6lv9q-vTcc-wnH_6YP1vU_H8SEZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629965462</pqid></control><display><type>article</type><title>Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lohr, B ; Müller, I ; Mai, M ; Norris, D E ; Schöffski, O ; Hunfeld, K-P</creator><creatorcontrib>Lohr, B ; Müller, I ; Mai, M ; Norris, D E ; Schöffski, O ; Hunfeld, K-P</creatorcontrib><description>To date, relatively little is known about the economic and medical impact of Lyme borreliosis (LB) on European health care systems, especially for the inpatient sector. This retrospective analysis is based on data provided for the years 2007-2011 by a German statutory health insurance company (DAK-Gesundheit) covering approximately 6 million insured. Total cost was calculated for a 1-year period both from the third-party payers and from the societal perspective, respectively. In our cohort the incident diagnosis of LB was coded for 2163 inpatient cases during the years 2008-2011. The median inpatient time was 9 days resulting in a median direct medical cost per hospital stay of 3917€ for adolescents and 2843€ for adults. Based on extrapolation of our findings to the German population, we would expect an average hospital admission of 5200 adults and 2300 adolescents (<18 years) for LB treatment incurring direct medical costs of more than 23 million Euro annually. The annual indirect costs due to loss of productivity would add up to more than 7 million Euro as assessed by the human capital method. Cases tended to accumulate between June and September with remarkable changes in disease manifestations in the course of the year documented in the coded secondary diagnoses. Also specific differences in the disease pattern of adolescents and adults became obvious. Age-specific incidence showed male predominance and a bimodal distribution. Incidence was highest in children aged between 3 and 17 (highest mean incidence of 29 cases/100,000 inhabitants in 6-9 year olds) with a second peak in 60-79 year old individuals. During the study period the nationwide inpatient incidence was 9/100,000 with marked regional variability. In summary, our study is one of the first European investigations on hospital care for LB inpatients and identifies LB as a possibly underestimated socioeconomic factor for health care in Germany.</description><identifier>ISSN: 1877-959X</identifier><identifier>EISSN: 1877-9603</identifier><identifier>DOI: 10.1016/j.ttbdis.2014.09.004</identifier><identifier>PMID: 25448420</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Adolescent ; Adult ; Aged ; Borrelia burgdorferi - physiology ; Child ; Child, Preschool ; Cohort Studies ; Female ; Germany - epidemiology ; Hospitalization - economics ; Humans ; Incidence ; Lyme Disease - economics ; Lyme Disease - epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Seasons ; Young Adult</subject><ispartof>Ticks and tick-borne diseases, 2015-02, Vol.6 (1), p.56-62</ispartof><rights>Copyright © 2014 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c307t-2e5b2298da39f4ef162a6f8a57fcb6973c142f62aaa164556b290934ce2521a3</citedby><cites>FETCH-LOGICAL-c307t-2e5b2298da39f4ef162a6f8a57fcb6973c142f62aaa164556b290934ce2521a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25448420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lohr, B</creatorcontrib><creatorcontrib>Müller, I</creatorcontrib><creatorcontrib>Mai, M</creatorcontrib><creatorcontrib>Norris, D E</creatorcontrib><creatorcontrib>Schöffski, O</creatorcontrib><creatorcontrib>Hunfeld, K-P</creatorcontrib><title>Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis</title><title>Ticks and tick-borne diseases</title><addtitle>Ticks Tick Borne Dis</addtitle><description>To date, relatively little is known about the economic and medical impact of Lyme borreliosis (LB) on European health care systems, especially for the inpatient sector. This retrospective analysis is based on data provided for the years 2007-2011 by a German statutory health insurance company (DAK-Gesundheit) covering approximately 6 million insured. Total cost was calculated for a 1-year period both from the third-party payers and from the societal perspective, respectively. In our cohort the incident diagnosis of LB was coded for 2163 inpatient cases during the years 2008-2011. The median inpatient time was 9 days resulting in a median direct medical cost per hospital stay of 3917€ for adolescents and 2843€ for adults. Based on extrapolation of our findings to the German population, we would expect an average hospital admission of 5200 adults and 2300 adolescents (<18 years) for LB treatment incurring direct medical costs of more than 23 million Euro annually. The annual indirect costs due to loss of productivity would add up to more than 7 million Euro as assessed by the human capital method. Cases tended to accumulate between June and September with remarkable changes in disease manifestations in the course of the year documented in the coded secondary diagnoses. Also specific differences in the disease pattern of adolescents and adults became obvious. Age-specific incidence showed male predominance and a bimodal distribution. Incidence was highest in children aged between 3 and 17 (highest mean incidence of 29 cases/100,000 inhabitants in 6-9 year olds) with a second peak in 60-79 year old individuals. During the study period the nationwide inpatient incidence was 9/100,000 with marked regional variability. In summary, our study is one of the first European investigations on hospital care for LB inpatients and identifies LB as a possibly underestimated socioeconomic factor for health care in Germany.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Borrelia burgdorferi - physiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Hospitalization - economics</subject><subject>Humans</subject><subject>Incidence</subject><subject>Lyme Disease - economics</subject><subject>Lyme Disease - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Seasons</subject><subject>Young Adult</subject><issn>1877-959X</issn><issn>1877-9603</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1r3DAQhkVJaUKafxCKjrmsK8mybPVWQpoWFnLJITcxtkdZLbK11WgPzik_vQ6bdC4zDO8HPIxdS1FJIc33fVVKPwaqlJC6ErYSQn9iF7Jr2401oj77uBv7dM6uiPZinVrqrlVf2LlqtO60Ehfs9e4QRpxCiul54TCPfEhUePJ8l-gQCkQ-QEbuU-bbZULep5wxhkSBeJj5PeYJ5uUHj0iUZuI-p4kD3yHEsjt5jyXE8AIlpJmPUKAHwrUK4rKGfGWfPUTCq_d9yR5_3T3e_t5sH-7_3P7cboZatGWjsOmVst0ItfUavTQKjO-gaf3QG9vWg9TKr08AaXTTmF5ZYWs9oGqUhPqS3ZxiDzn9PSIVNwUaMEaYMR3JrXnWmkYbtUr1STrkRJTRu0MOE-TFSeHe6Lu9O9F3b_SdsG6lv9q-vTcc-wnH_6YP1vU_H8SEZQ</recordid><startdate>201502</startdate><enddate>201502</enddate><creator>Lohr, B</creator><creator>Müller, I</creator><creator>Mai, M</creator><creator>Norris, D E</creator><creator>Schöffski, O</creator><creator>Hunfeld, K-P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201502</creationdate><title>Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis</title><author>Lohr, B ; Müller, I ; Mai, M ; Norris, D E ; Schöffski, O ; Hunfeld, K-P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-2e5b2298da39f4ef162a6f8a57fcb6973c142f62aaa164556b290934ce2521a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Borrelia burgdorferi - physiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Hospitalization - economics</topic><topic>Humans</topic><topic>Incidence</topic><topic>Lyme Disease - economics</topic><topic>Lyme Disease - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Seasons</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lohr, B</creatorcontrib><creatorcontrib>Müller, I</creatorcontrib><creatorcontrib>Mai, M</creatorcontrib><creatorcontrib>Norris, D E</creatorcontrib><creatorcontrib>Schöffski, O</creatorcontrib><creatorcontrib>Hunfeld, K-P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ticks and tick-borne diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lohr, B</au><au>Müller, I</au><au>Mai, M</au><au>Norris, D E</au><au>Schöffski, O</au><au>Hunfeld, K-P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis</atitle><jtitle>Ticks and tick-borne diseases</jtitle><addtitle>Ticks Tick Borne Dis</addtitle><date>2015-02</date><risdate>2015</risdate><volume>6</volume><issue>1</issue><spage>56</spage><epage>62</epage><pages>56-62</pages><issn>1877-959X</issn><eissn>1877-9603</eissn><abstract>To date, relatively little is known about the economic and medical impact of Lyme borreliosis (LB) on European health care systems, especially for the inpatient sector. This retrospective analysis is based on data provided for the years 2007-2011 by a German statutory health insurance company (DAK-Gesundheit) covering approximately 6 million insured. Total cost was calculated for a 1-year period both from the third-party payers and from the societal perspective, respectively. In our cohort the incident diagnosis of LB was coded for 2163 inpatient cases during the years 2008-2011. The median inpatient time was 9 days resulting in a median direct medical cost per hospital stay of 3917€ for adolescents and 2843€ for adults. Based on extrapolation of our findings to the German population, we would expect an average hospital admission of 5200 adults and 2300 adolescents (<18 years) for LB treatment incurring direct medical costs of more than 23 million Euro annually. The annual indirect costs due to loss of productivity would add up to more than 7 million Euro as assessed by the human capital method. Cases tended to accumulate between June and September with remarkable changes in disease manifestations in the course of the year documented in the coded secondary diagnoses. Also specific differences in the disease pattern of adolescents and adults became obvious. Age-specific incidence showed male predominance and a bimodal distribution. Incidence was highest in children aged between 3 and 17 (highest mean incidence of 29 cases/100,000 inhabitants in 6-9 year olds) with a second peak in 60-79 year old individuals. During the study period the nationwide inpatient incidence was 9/100,000 with marked regional variability. In summary, our study is one of the first European investigations on hospital care for LB inpatients and identifies LB as a possibly underestimated socioeconomic factor for health care in Germany.</abstract><cop>Netherlands</cop><pmid>25448420</pmid><doi>10.1016/j.ttbdis.2014.09.004</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1877-959X |
| ispartof | Ticks and tick-borne diseases, 2015-02, Vol.6 (1), p.56-62 |
| issn | 1877-959X 1877-9603 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1629965462 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Aged Borrelia burgdorferi - physiology Child Child, Preschool Cohort Studies Female Germany - epidemiology Hospitalization - economics Humans Incidence Lyme Disease - economics Lyme Disease - epidemiology Male Middle Aged Retrospective Studies Seasons Young Adult |
| title | Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A03%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiology%20and%20cost%20of%20hospital%20care%20for%20Lyme%20borreliosis%20in%20Germany:%20lessons%20from%20a%20health%20care%20utilization%20database%20analysis&rft.jtitle=Ticks%20and%20tick-borne%20diseases&rft.au=Lohr,%20B&rft.date=2015-02&rft.volume=6&rft.issue=1&rft.spage=56&rft.epage=62&rft.pages=56-62&rft.issn=1877-959X&rft.eissn=1877-9603&rft_id=info:doi/10.1016/j.ttbdis.2014.09.004&rft_dat=%3Cproquest_cross%3E1629965462%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629965462&rft_id=info:pmid/25448420&rfr_iscdi=true |